Uscom Ltd (UCM) - Net Assets
Based on the latest financial reports, Uscom Ltd (UCM) has net assets worth AU$182.80K AUD (≈ $129.34K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$460.89K ≈ $326.11K USD) and total liabilities (AU$278.09K ≈ $196.77K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Uscom Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$182.80K |
| % of Total Assets | 39.66% |
| Annual Growth Rate | N/A |
| 5-Year Change | -101.24% |
| 10-Year Change | -100.77% |
| Growth Volatility | 48.02 |
Uscom Ltd - Net Assets Trend (2003–2025)
This chart illustrates how Uscom Ltd's net assets have evolved over time, based on quarterly financial data. See Uscom Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Uscom Ltd (2003–2025)
The table below shows the annual net assets of Uscom Ltd from 2003 to 2025. For live valuation and market cap data, see market value of Uscom Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$-38.22K ≈ $-27.05K |
-101.25% |
| 2024-06-30 | AU$3.06 Million ≈ $2.17 Million |
+0.56% |
| 2023-06-30 | AU$3.04 Million ≈ $2.15 Million |
-48.71% |
| 2022-06-30 | AU$5.94 Million ≈ $4.20 Million |
+92.85% |
| 2021-06-30 | AU$3.08 Million ≈ $2.18 Million |
-10.07% |
| 2020-06-30 | AU$3.42 Million ≈ $2.42 Million |
-1.88% |
| 2019-06-30 | AU$3.49 Million ≈ $2.47 Million |
-28.01% |
| 2018-06-30 | AU$4.84 Million ≈ $3.43 Million |
+28.24% |
| 2017-06-30 | AU$3.78 Million ≈ $2.67 Million |
-23.49% |
| 2016-06-30 | AU$4.94 Million ≈ $3.49 Million |
+115.76% |
| 2015-06-30 | AU$2.29 Million ≈ $1.62 Million |
-31.05% |
| 2014-06-30 | AU$3.32 Million ≈ $2.35 Million |
+40.97% |
| 2013-06-30 | AU$2.35 Million ≈ $1.67 Million |
+60.17% |
| 2012-06-30 | AU$1.47 Million ≈ $1.04 Million |
-53.12% |
| 2011-06-30 | AU$3.14 Million ≈ $2.22 Million |
+27.98% |
| 2010-06-30 | AU$2.45 Million ≈ $1.73 Million |
-19.83% |
| 2009-06-30 | AU$3.06 Million ≈ $2.16 Million |
-10.26% |
| 2008-06-30 | AU$3.41 Million ≈ $2.41 Million |
-38.04% |
| 2007-06-30 | AU$5.50 Million ≈ $3.89 Million |
-35.41% |
| 2006-06-30 | AU$8.51 Million ≈ $6.02 Million |
-27.56% |
| 2005-06-30 | AU$11.75 Million ≈ $8.31 Million |
-17.81% |
| 2004-06-30 | AU$14.29 Million ≈ $10.11 Million |
-7.45% |
| 2003-06-30 | AU$15.44 Million ≈ $10.93 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Uscom Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4372456400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$40.44 Million | % |
| Other Comprehensive Income | AU$4.41 Million | % |
| Total Equity | AU$-38.22K | 100.00% |
Uscom Ltd Competitors by Market Cap
The table below lists competitors of Uscom Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vp plc
LSE:VP
|
$2.21 Million |
|
Crest Nicholson Holdings plc
LSE:CRST
|
$2.22 Million |
|
Magle Chemoswed Holding Ab
ST:MAGLE
|
$2.22 Million |
|
UIL Ltd
LSE:UTL
|
$2.22 Million |
|
Grand Gulf Energy Ltd
AU:GGE
|
$2.21 Million |
|
Global Health Ltd
AU:GLH
|
$2.20 Million |
|
Chesterfield Resources PLC
LSE:CHF
|
$2.20 Million |
|
CCSC Technology International Holdings Limited Ordinary Shares
NASDAQ:CCTG
|
$2.20 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Uscom Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,061,050 to -38,224, a change of -3,099,274 (-101.2%).
- Net loss of 3,302,759 reduced equity.
- Other comprehensive income increased equity by 191,463.
- Other factors increased equity by 12,022.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-3.30 Million | -8640.54% |
| Other Comprehensive Income | AU$191.46K | +500.9% |
| Other Changes | AU$12.02K | +31.45% |
| Total Change | AU$- | -101.25% |
Book Value vs Market Value Analysis
This analysis compares Uscom Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-06-30 | AU$0.41 | AU$0.01 | x |
| 2004-06-30 | AU$0.41 | AU$0.01 | x |
| 2005-06-30 | AU$0.30 | AU$0.01 | x |
| 2006-06-30 | AU$0.22 | AU$0.01 | x |
| 2007-06-30 | AU$0.14 | AU$0.01 | x |
| 2008-06-30 | AU$0.09 | AU$0.01 | x |
| 2009-06-30 | AU$0.08 | AU$0.01 | x |
| 2010-06-30 | AU$0.06 | AU$0.01 | x |
| 2011-06-30 | AU$0.07 | AU$0.01 | x |
| 2012-06-30 | AU$0.03 | AU$0.01 | x |
| 2013-06-30 | AU$0.04 | AU$0.01 | x |
| 2014-06-30 | AU$0.04 | AU$0.01 | x |
| 2015-06-30 | AU$0.03 | AU$0.01 | x |
| 2016-06-30 | AU$0.05 | AU$0.01 | x |
| 2017-06-30 | AU$0.03 | AU$0.01 | x |
| 2018-06-30 | AU$0.04 | AU$0.01 | x |
| 2019-06-30 | AU$0.03 | AU$0.01 | x |
| 2020-06-30 | AU$0.02 | AU$0.01 | x |
| 2021-06-30 | AU$0.02 | AU$0.01 | x |
| 2022-06-30 | AU$0.03 | AU$0.01 | x |
| 2023-06-30 | AU$0.02 | AU$0.01 | x |
| 2024-06-30 | AU$0.02 | AU$0.01 | x |
| 2025-06-30 | AU$0.00 | AU$0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Uscom Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -128.07%
- • Asset Turnover: 0.79x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-49.48%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | -8.76% | -325.63% | 0.03x | 1.02x | AU$-2.68 Million |
| 2005 | -21.67% | -530.28% | 0.04x | 1.03x | AU$-3.72 Million |
| 2006 | -39.65% | -301.37% | 0.12x | 1.08x | AU$-4.23 Million |
| 2007 | -58.16% | -366.92% | 0.15x | 1.08x | AU$-3.75 Million |
| 2008 | -63.85% | -206.76% | 0.28x | 1.10x | AU$-2.52 Million |
| 2009 | -35.99% | -67.46% | 0.46x | 1.15x | AU$-1.41 Million |
| 2010 | -71.74% | -210.02% | 0.30x | 1.16x | AU$-2.00 Million |
| 2011 | -85.66% | -320.52% | 0.24x | 1.12x | AU$-3.00 Million |
| 2012 | -124.11% | -229.75% | 0.43x | 1.24x | AU$-1.97 Million |
| 2013 | -58.25% | -237.01% | 0.21x | 1.20x | AU$-1.61 Million |
| 2014 | -45.81% | -143.92% | 0.28x | 1.14x | AU$-1.85 Million |
| 2015 | -53.12% | -59.61% | 0.69x | 1.28x | AU$-1.44 Million |
| 2016 | -38.78% | -65.21% | 0.51x | 1.16x | AU$-2.41 Million |
| 2017 | -47.67% | -51.47% | 0.78x | 1.19x | AU$-2.18 Million |
| 2018 | -40.48% | -68.52% | 0.53x | 1.11x | AU$-2.45 Million |
| 2019 | -39.83% | -38.15% | 0.88x | 1.19x | AU$-1.74 Million |
| 2020 | -38.90% | -38.26% | 0.59x | 1.73x | AU$-1.67 Million |
| 2021 | -30.03% | -23.96% | 0.72x | 1.73x | AU$-1.23 Million |
| 2022 | -33.23% | -78.59% | 0.31x | 1.35x | AU$-2.57 Million |
| 2023 | -85.11% | -97.25% | 0.51x | 1.70x | AU$-2.90 Million |
| 2024 | -67.78% | -55.67% | 0.73x | 1.68x | AU$-2.38 Million |
| 2025 | 0.00% | -128.07% | 0.79x | 0.00x | AU$-3.30 Million |
Industry Comparison
This section compares Uscom Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $66,808,656
- Average return on equity (ROE) among peers: -60.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Uscom Ltd (UCM) | AU$182.80K | -8.76% | 1.52x | $2.21 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.84 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $7.60 Million |
| Aroa Biosurgery Ltd (ARX) | $7.58 Million | -19.34% | 0.11x | $154.57 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $12.75 Million |
| Avita Medical Inc (AVH) | $147.08 Million | -23.53% | 0.09x | $119.77 Million |
| Anteris Technologies Global Corp (AVR) | $28.66 Million | -234.92% | 0.59x | $848.00 Million |
| Control Bionics Ltd (CBL) | $6.27 Million | -94.35% | 0.44x | $26.53 Million |
| Cardiex Ltd (CDX) | $1.88 Million | -105.36% | 1.22x | $13.23 Million |
| Compumedics Ltd (CMP) | $21.79 Million | -26.79% | 0.63x | $35.62 Million |
| Cochlear Ltd (COH) | $384.88 Million | 14.76% | 0.83x | $5.47 Billion |
About Uscom Ltd
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices in Australia, Asia, the Americas, and Europe. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures blood flow, stroke volume, and cardiac output; and BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure w… Read more